394 related articles for article (PubMed ID: 11657602)
1. Federal agency revises rule on financial disclosure by researchers.
Maloney DM
Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
[No Abstract] [Full Text] [Related]
2. Conflicts of interest.
Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
[No Abstract] [Full Text] [Related]
3. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
4. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
5. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
6. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
7. Agency seeks approval of financial disclosure steps for researchers.
Maloney DM
Hum Res Rep; 2002 Mar; 17(3):1-2. PubMed ID: 12408150
[No Abstract] [Full Text] [Related]
8. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
9. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
Jordan KA
Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
[No Abstract] [Full Text] [Related]
10. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information.
Samuels A
Account Res; 1999; 6(4):259-310. PubMed ID: 11657840
[No Abstract] [Full Text] [Related]
11. In business to treat cancer.
Henig RM
N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805
[No Abstract] [Full Text] [Related]
12. The regulation of clinical investigators.
Endries RN
Food Drug Cosmet Law J; 1980 Jul; 35(7):415-23. PubMed ID: 11661860
[No Abstract] [Full Text] [Related]
13. Researchers must inform subjects about financial incentives for study.
Maloney DM
Hum Res Rep; 1999 Aug; 14(8):6. PubMed ID: 11657806
[No Abstract] [Full Text] [Related]
14. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
15. Bioethics and applied biomaterials.
Saha S; Saha P
J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
[No Abstract] [Full Text] [Related]
16. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
17. Data monitoring committees: the moral case for maximum feasible independence.
Walters L
Stat Med; 1993 Mar; 12(5-6):575-80. PubMed ID: 11659537
[No Abstract] [Full Text] [Related]
18. The role and responsibility of industry in research.
Lasagna L
Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
[No Abstract] [Full Text] [Related]
19. Financial conflicts of interest in biomedical human subject research.
Goldstein N
J Biolaw Bus; 2006; 9(1):26-37. PubMed ID: 17111525
[TBL] [Abstract][Full Text] [Related]
20. The troublesome semantics of conflict of interest.
Friedman PJ
Ethics Behav; 1992; 2(4):245-51. PubMed ID: 11651613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
